Skip to content
777 Sourcing.

Capability

protein degradation

Suppliers
1
States & provinces
1
Countries
1

1 protein degradation supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Dialectic Therapeutics is a clinical-stage biotechnology company based in Dallas, Texas, dedicated to developing innovative anti-cancer drugs. Its lead candidate, DT2216, is built on its proprietary Antiapoptotic Protein Targeted Degradation (APTaD™) technology platform and selectively induces cancer cells to degrade BCL-XL. DT2216 is in Phase 1/2 clinical trials for Fibrolamellar Carcinoma and Platinum-Resistant Ovarian Cancer.

clinical trialsdrug developmentmedicinal chemistry

Related capabilities

Other processes offered by the shops that list protein degradation.

Browse all capabilities